These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 8625325

  • 1. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.
    Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Kamidono S.
    Cancer Res; 1996 May 15; 56(10):2440-5. PubMed ID: 8625325
    [Abstract] [Full Text] [Related]

  • 2. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H, Hara I, Gohji K, Yamanaka K, Hara S, Arakawa S, Nakajima M, Kamidono S.
    Clin Cancer Res; 1999 Oct 15; 5(10):2824-9. PubMed ID: 10537348
    [Abstract] [Full Text] [Related]

  • 3. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.
    Miyake H, Yoshimura K, Hara I, Eto H, Arakawa S, Kamidono S.
    J Urol; 1997 Jun 15; 157(6):2351-5. PubMed ID: 9146669
    [Abstract] [Full Text] [Related]

  • 4. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 15; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 5. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K, Wong L, Liu V, Park I, Zhang Q, Rejen V, Huang X, Smith ND, Jovanovic B, Lonning S, Teicher BA, Lee C.
    Urology; 2008 Jul 15; 72(1):225-9. PubMed ID: 18295867
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
    Ogushi T, Takahashi S, Takeuchi T, Urano T, Horie-Inoue K, Kumagai J, Kitamura T, Ouchi Y, Muramatsu M, Inoue S.
    Cancer Res; 2005 May 01; 65(9):3700-6. PubMed ID: 15867365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK, Viitanen TP, Valve EM, Seppänen JA, Loponen NT, Keskitalo JJ, Lakkakorpi PT, Härkönen PL.
    Cancer Res; 2001 May 15; 61(10):4229-37. PubMed ID: 11358849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
    Miyake H, Hara I, Yamanaka K, Muramaki M, Gleave M, Eto H.
    Oncol Rep; 2005 Feb 15; 13(2):341-5. PubMed ID: 15643522
    [Abstract] [Full Text] [Related]

  • 12. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J, Nakamoto T, Kasaoka Y, Usui T, Hamada H.
    Hiroshima J Med Sci; 2000 Mar 15; 49(1):73-82. PubMed ID: 10824460
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
    Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP.
    Cancer Res; 2000 Apr 15; 60(8):2290-9. PubMed ID: 10786697
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [Abstract] [Full Text] [Related]

  • 15. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines.
    Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW, McCormick JJ.
    Oncogene; 1997 Oct 15; 15(18):2159-68. PubMed ID: 9393974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.
    Tan J, Newton CA, Djeu JY, Gutsch DE, Chang AE, Yang NS, Klein TW, Hua Y.
    Cancer Res; 1996 Aug 01; 56(15):3399-403. PubMed ID: 8758901
    [Abstract] [Full Text] [Related]

  • 19. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 20. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.
    Oncogene; 2001 Jun 07; 20(26):3363-75. PubMed ID: 11423987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.